CMNSG Guest Lecture. Interleukin-1, interleukin-1 receptor, and interleukin-1 receptor antagonist. 1994

N J Espat, and M A Rogy, and E M Copeland, and L L Moldawer
Department of Surgery, College of Medicine, University of Florida, Gainesville 32610-0268.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012795 Sialoglycoproteins Glycoproteins which contain sialic acid as one of their carbohydrates. They are often found on or in the cell or tissue membranes and participate in a variety of biological activities. Polysialoglycoprotein,Sialoglycopeptide,Sialoglycopeptides,Sialoglycoprotein,Sialoprotein,Sialoproteins,Polysialoglycoproteins
D017472 Receptors, Interleukin-1 Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading are signaling receptors, non-signaling receptors and accessory proteins required for receptor signaling. Signaling from interleukin-1 receptors occurs via interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88. IL-1 Receptor,IL-1 Receptors,IL1 Receptor,Interleukin-1 Receptor,Interleukin-1 Receptors,Receptor, Interleukin-1,Receptors, IL-1,IL1 Receptors,Interleukin 1 Receptor,IL 1 Receptor,IL 1 Receptors,Interleukin 1 Receptors,Receptor, IL-1,Receptor, IL1,Receptor, Interleukin 1,Receptors, IL 1,Receptors, IL1,Receptors, Interleukin 1
D053590 Interleukin 1 Receptor Antagonist Protein A ligand that binds to but fails to activate the INTERLEUKIN 1 RECEPTOR. It plays an inhibitory role in the regulation of INFLAMMATION and FEVER. Several isoforms of the protein exist due to multiple ALTERNATIVE SPLICING of its mRNA. Anakinra,Antril,IL-1 Inhibitor, Urine,IL-1Ra,IL1 Febrile Inhibitor,Interleukin 1 Inhibitor, Urine,Kineret,Urine-Derived IL1 Inhibitor,Febrile Inhibitor, IL1,IL 1 Inhibitor, Urine,IL1 Inhibitor, Urine-Derived,Urine Derived IL1 Inhibitor,Urine IL-1 Inhibitor

Related Publications

N J Espat, and M A Rogy, and E M Copeland, and L L Moldawer
January 1995, Nutrition (Burbank, Los Angeles County, Calif.),
N J Espat, and M A Rogy, and E M Copeland, and L L Moldawer
January 1998, International reviews of immunology,
N J Espat, and M A Rogy, and E M Copeland, and L L Moldawer
January 1993, Advances in immunology,
N J Espat, and M A Rogy, and E M Copeland, and L L Moldawer
August 1998, Rheumatic diseases clinics of North America,
N J Espat, and M A Rogy, and E M Copeland, and L L Moldawer
January 1995, Critical reviews in immunology,
N J Espat, and M A Rogy, and E M Copeland, and L L Moldawer
June 1997, Seminars in oncology,
N J Espat, and M A Rogy, and E M Copeland, and L L Moldawer
January 1991, Annales de medecine interne,
N J Espat, and M A Rogy, and E M Copeland, and L L Moldawer
December 1992, Canadian journal of physiology and pharmacology,
N J Espat, and M A Rogy, and E M Copeland, and L L Moldawer
February 1991, The American journal of physiology,
N J Espat, and M A Rogy, and E M Copeland, and L L Moldawer
January 1997, Immunological investigations,
Copied contents to your clipboard!